Capital Management Associates (New York)’s Thermo Fisher Scientific TMO Stock Holding History

Capital Management Associates (New York)’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Hold	2,100	–	–	1.71%	27
2025 Q4	$1.22M	Buy	2,100 +800	+62%	+$452K	1.78%	30
2025 Q3	$631K	Hold	1,300	–	–	0.94%	36
2025 Q2	$527K	Hold	1,300	–	–	0.86%	39
2025 Q1	$647K	Hold	1,300	–	–	1.26%	33
2024 Q4	$676K	Hold	1,300	–	–	0.8%	47
2024 Q3	$804K	Sell	1,300 -200	-13%	-$118K	0.9%	47
2024 Q2	$830K	Hold	1,500	–	–	0.98%	43
2024 Q1	$872K	Hold	1,500	–	–	1.04%	43
2023 Q4	$796K	Hold	1,500	–	–	1.01%	46
2023 Q3	$759K	Hold	1,500	–	–	1.12%	33
2023 Q2	$783K	Hold	1,500	–	–	1.15%	36
2023 Q1	$865K	Hold	1,500	–	–	1.31%	32
2022 Q4	$826K	Sell	1,500 -1,200	-44%	-$636K	1.23%	39
2022 Q3	$1.37M	Hold	2,700	–	–	1.99%	14
2022 Q2	$1.47M	Hold	2,700	–	–	2.16%	14
2022 Q1	$1.59M	Sell	2,700 -900	-25%	-$517K	1.71%	17
2021 Q4	$2.4M	Hold	3,600	–	–	2.35%	8
2021 Q3	$2.06M	Hold	3,600	–	–	2.03%	12
2021 Q2	$1.82M	Hold	3,600	–	–	1.74%	12
2021 Q1	$1.64M	Hold	3,600	–	–	1.69%	14
2020 Q4	$1.68M	Hold	3,600	–	–	1.83%	11
2020 Q3	$1.59M	Hold	3,600	–	–	2.1%	11
2020 Q2	$1.3M	Hold	3,600	–	–	1.84%	15
2020 Q1	$1.02M	Buy	3,600 +600	+20%	+$189K	1.84%	16
2019 Q4	$975K	Hold	3,000	–	–	1.35%	25
2019 Q3	$874K	Hold	3,000	–	–	1.35%	22
2019 Q2	$881K	Hold	3,000	–	–	1.43%	17
2019 Q1	$821K	Hold	3,000	–	–	1.28%	24
2018 Q4	$671K	Hold	3,000	–	–	1.27%	25
2018 Q3	$732K	Hold	3,000	–	–	0.91%	36
2018 Q2	$621K	Buy	+3,000	New	+$637K	0.78%	55

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Management Associates (New York)'s TMO Position: Q1 2026 in Review

Capital Management Associates (New York) held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 2,100 shares worth $1.03M. The position accounts for 1.71% of the portfolio, ranked #27.

Capital Management Associates (New York) first reported a position in TMO in Q2 2018 and has held it in 32 quarters since. The position peaked at $2.4M in Q4 2021. 2,592 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Capital Management Associates (New York) held 2,100 shares of Thermo Fisher Scientific worth $1.03M as of Q1 2026.
Capital Management Associates (New York) left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 1.71% of Capital Management Associates (New York)'s portfolio in Q1 2026, its #27 holding.
Capital Management Associates (New York) first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 32 quarters since.
Capital Management Associates (New York)'s Thermo Fisher Scientific position peaked at $2.4M in Q4 2021.
2,592 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Capital Management Associates (New York)'s 13F filing for Q1 2026, filed 4 May 2026.